Clipped histone H3 is integrated into nucleosomes of DNA replication genes in the human malaria parasite Plasmodium falciparum.
Abril Marcela Herrera-SolorioShruthi Sridhar VembarCameron Ross MacPhersonDaniela Lozano-AmadoGabriela Romero MezaBeatriz Xoconostle-CazaresRafael Miyazawa MartinsPatty ChenMiguel VargasArtur ScherfRosaura Hernandez-RivasPublished in: EMBO reports (2019)
Post-translational modifications of histone H3 N-terminal tails are key epigenetic regulators of virulence gene expression and sexual commitment in the human malaria parasite Plasmodium falciparum Here, we identify proteolytic clipping of the N-terminal tail of nucleosome-associated histone H3 at amino acid position 21 as a new chromatin modification. A cathepsin C-like proteolytic clipping activity is observed in nuclear parasite extracts. Notably, an ectopically expressed version of clipped histone H3, PfH3p-HA, is targeted to the nucleus and integrates into mononucleosomes. Furthermore, chromatin immunoprecipitation and next-generation sequencing analysis identified PfH3p-HA as being highly enriched in the upstream region of six genes that play a key role in DNA replication and repair: In these genes, PfH3p-HA demarcates a specific 1.5 kb chromatin island adjacent to the open reading frame. Our results indicate that, in P. falciparum, the process of histone clipping may precede chromatin integration hinting at preferential targeting of pre-assembled PfH3p-containing nucleosomes to specific genomic regions. The discovery of a protease-directed mode of chromatin organization in P. falciparum opens up new avenues to develop new anti-malarials.
Keyphrases
- plasmodium falciparum
- gene expression
- genome wide
- dna methylation
- transcription factor
- copy number
- dna damage
- endothelial cells
- genome wide identification
- amino acid
- induced pluripotent stem cells
- escherichia coli
- bioinformatics analysis
- cancer therapy
- pseudomonas aeruginosa
- mental health
- minimally invasive
- small molecule
- oxidative stress
- working memory
- drug delivery
- cystic fibrosis
- antimicrobial resistance
- genome wide analysis